| 0.2 |
0.5 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.2 |
0.6 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 |
0.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.3 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.1 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.2 |
GO:1901143 |
insulin catabolic process(GO:1901143) |
| 0.1 |
0.2 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.1 |
0.2 |
GO:1902361 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 |
0.3 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.2 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 |
0.1 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.0 |
0.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.1 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.0 |
0.2 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.0 |
0.3 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.2 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 |
0.2 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.0 |
0.1 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 |
0.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.2 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.0 |
0.3 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.1 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.0 |
0.1 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.1 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.0 |
0.1 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.0 |
0.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.0 |
0.3 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
0.2 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.0 |
0.2 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 0.0 |
0.1 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.0 |
0.4 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.1 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.0 |
0.0 |
GO:0061341 |
non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.0 |
0.1 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.0 |
0.2 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.0 |
0.1 |
GO:1990168 |
protein K33-linked deubiquitination(GO:1990168) |
| 0.0 |
0.1 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 |
0.2 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.0 |
0.4 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.1 |
GO:0048372 |
lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.0 |
0.2 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.2 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 |
0.0 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.0 |
0.2 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.0 |
0.1 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.0 |
0.1 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.0 |
0.2 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.0 |
0.2 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.0 |
0.1 |
GO:2001288 |
positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 |
0.1 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.0 |
0.0 |
GO:0035283 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.0 |
0.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.0 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.4 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 |
0.1 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.0 |
0.2 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.1 |
GO:0009052 |
D-ribose metabolic process(GO:0006014) pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.0 |
0.1 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.0 |
0.1 |
GO:0021816 |
lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.0 |
0.0 |
GO:0072095 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
| 0.0 |
0.1 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.0 |
0.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.0 |
0.2 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.1 |
GO:2001170 |
negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.0 |
0.1 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
0.1 |
GO:0070839 |
divalent metal ion export(GO:0070839) |
| 0.0 |
0.3 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.0 |
0.3 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 |
0.0 |
GO:0030805 |
regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 0.0 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 |
0.1 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.0 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.1 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.0 |
0.1 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.0 |
0.1 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.1 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.0 |
0.2 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.1 |
GO:0006499 |
N-terminal protein myristoylation(GO:0006499) |
| 0.0 |
0.1 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.0 |
0.1 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.0 |
0.0 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.1 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.0 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 |
0.0 |
GO:0038111 |
interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 |
0.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:1900239 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.0 |
0.1 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
0.0 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.0 |
0.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.0 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.0 |
0.1 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 |
0.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.0 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.0 |
0.2 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.0 |
0.2 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.0 |
0.1 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.0 |
GO:0021769 |
orbitofrontal cortex development(GO:0021769) |
| 0.0 |
0.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
